BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kamdje AHN, Etet PFS, Simo RT, Vecchio L, Lukong KE, Krampera M. Emerging data supporting stromal cell therapeutic potential in cancer: reprogramming stromal cells of the tumor microenvironment for anti-cancer effects. Cancer Biol Med 2020;17:828-41. [PMID: 33299638 DOI: 10.20892/j.issn.2095-3941.2020.0133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tian C, Li Y, Wang L, Si J, Zheng Y, Kang J, Wang Y, You MJ, Zheng G. Blockade of FGF2/FGFR2 partially overcomes bone marrow mesenchymal stromal cells mediated progression of T-cell acute lymphoblastic leukaemia. Cell Death Dis 2022;13:922. [DOI: 10.1038/s41419-022-05377-5] [Reference Citation Analysis]
2 Xu M, Zhang T, Xia R, Wei Y, Wei X. Targeting the tumor stroma for cancer therapy. Mol Cancer 2022;21:208. [PMID: 36324128 DOI: 10.1186/s12943-022-01670-1] [Reference Citation Analysis]
3 Taurino G, Deshmukh R, Villar VH, Chiu M, Shaw R, Hedley A, Shokry E, Sumpton D, Dander E, D'Amico G, Bussolati O, Tardito S. Mesenchymal stromal cells cultured in physiological conditions sustain citrate secretion with glutamate anaplerosis. Mol Metab 2022;:101532. [PMID: 35752287 DOI: 10.1016/j.molmet.2022.101532] [Reference Citation Analysis]
4 Hamilton G, Teufelsbauer M. Adipose-derived stromal/stem cells and extracellular vesicles for cancer therapy. Expert Opin Biol Ther 2021;:1-12. [PMID: 34236014 DOI: 10.1080/14712598.2021.1954156] [Reference Citation Analysis]